Research programs using large compound or sample repositories, such as those prevalent in the drug discovery industry, require efficient management to maximize usability and minimize costs. Such ...
This article is based on a poster originally authored by Carl Haslam. Design, Make, Test, and Analyze (DMTA) screening involves generating compound assay-ready plates (ARP). However, this process can ...
The design, make, test, and analyze cycle (DMTA), which drives early-stage drug discovery, requires workflows and automated methods for sample storage and tracking, low volume dispensing of ...
The comPOUND® modular system comprises a high-density sample storage unit and an additional suite of specialised delivery and processing modules to enable easy integration into any compound management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results